Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration.

Bond, Leila; Bowen, Gloria; Mertens, Benjamin; Denson, Keelie; Jordan, Kathleen; Vidakovic, Branislav; Mitchell, Cassie S

Bond, Leila; Bowen, Gloria; Mertens, Benjamin; Denson, Keelie; Jordan, Kathleen; Vidakovic, Branislav; Mitchell, Cassie S.

Afiliação

Bond L; Department of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, GA 30332, USA.
Bowen G; Department of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, GA 30332, USA.
Mertens B; Department of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, GA 30332, USA.
Denson K; Department of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, GA 30332, USA.
Jordan K; School of Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Vidakovic B; Department of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, GA 30332, USA.
Mitchell CS; Department of Industrial & Systems Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.

Behav Sci (Basel) ; 10(1)2020 Jan 10.

Article em En | MEDLINE | ID: mdl-31936812

Palavras-chave

ALS; antidepressants; mood; off-label drugs; quality of life; supplements; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Behav Sci (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google